Immediate Impact

15 from Science/Nature 48 standout
Sub-graph 1 of 24

Citing Papers

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
2024 Standout
European Association of Urology Guidelines on Testicular Cancer: 2023 Update
2023 Standout
2 intermediate papers

Works of John R. Satterfield being referenced

Metastatic Teratocarcinoma Following Chemotherapy
1976
Studies of human myasthenia gravis: electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex.
1976

Author Peers

Author Last Decade Papers Cites
John R. Satterfield 98 176 138 10 358
Michael B. Kim 103 84 75 8 353
Imre Weitzner 140 123 44 15 370
A Brand 59 100 20 13 347
Rong-Guo Yu 45 77 58 13 307
Jeffrey Swanson 173 68 65 12 404
Brianna C. Theriault 80 169 42 12 391
C.E. Söderström 90 125 95 16 363
Lu Anne V. Dinglasan 47 122 14 10 320
Krista L. Hardy 242 94 32 12 350
AO Mansfield 37 156 197 8 317

All Works

Loading papers...

Rankless by CCL
2026